Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report
Nikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 2, pp. 283-291
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

MRI predictors of pharmacotherapy response in major depressive disorder
Andrew Gerlach, Helmet T. Karim, Marta Peciña, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103157-103157
Open Access | Times Cited: 41
Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Cynthia H.Y. Fu, Mathilde Antoniades, Güray Erus, et al.
Nature Mental Health (2024) Vol. 2, Iss. 2, pp. 164-176
Open Access | Times Cited: 11
Elevating the field for applying neuroimaging to individual patients in psychiatry
David R. Roalf, Martijn Figee, Desmond J. Oathes
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
The impact of adult neurogenesis on affective functions: of mice and men
Mariana Alonso, Anne‐Cécile Petit, Pierre‐Marie Lledo
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2527-2542
Open Access | Times Cited: 10
Full‐count PET recovery from low‐count image using a dilated convolutional neural network
Karl Spuhler, Mario Serrano‐Sosa, Renee Cattell, et al.
Medical Physics (2020) Vol. 47, Iss. 10, pp. 4928-4938
Open Access | Times Cited: 64
An assessment of the existence of adult neurogenesis in humans and value of its rodent models for neuropsychiatric diseases
Alvaro Duque, Jon I. Arellano, Pasko Rakić
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 377-382
Open Access | Times Cited: 50
Treatment resistant late-life depression: A narrative review of psychosocial risk factors, non-pharmacological interventions, and the role of clinical phenotyping
Regan Patrick, Rebecca A. Dickinson, Melanie T. Gentry, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 145-154
Closed Access | Times Cited: 5
Kynurenine Metabolism is Associated with Antidepressant Response to Selective Serotonin Reuptake Inhibitors
Ryan Rampersaud, Klara Suneson, Gwyneth W. Y. Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Cardiovascular Risk Predicts White Matter Hyperintensities, Brain Atrophy and Treatment Resistance in Major Depressive Disorder: Role of Genetic Liability
Marco Paolini, Melania Maccario, V. Saredi, et al.
Acta Psychiatrica Scandinavica (2025)
Open Access
Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study
Beatriz Pozuelo Moyano, Vasiliki Orgeta, Armin von Gunten, et al.
Journal of Affective Disorders (2025)
Closed Access
Therapeutic Opportunities for Food Supplements in Neurodegenerative Disease and Depression
Rita Businaro, David Vauzour, Jerome Sarris, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 29
Ketamine Normalizes the Structural Alterations of Inferior Frontal Gyrus in Depression
Dan Dai, Cheryl Lacadie, Sophie Holmes, et al.
Chronic Stress (2020) Vol. 4
Open Access | Times Cited: 29
Neuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine
Artemis Zavaliangos‐Petropulu, Noor Al‐Sharif, Brandon Taraku, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2022) Vol. 8, Iss. 4, pp. 361-386
Open Access | Times Cited: 18
Reduced gray matter volume of the hippocampal tail in melancholic depression: evidence from an MRI study
Zhaosong Chu, Lijin Yuan, Kun Lian, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Hippocampal subfield abnormalities and memory functioning in children with fetal alcohol Spectrum disorders
Donovan J. Roediger, Alyssa M. Krueger, Erik de Water, et al.
Neurotoxicology and Teratology (2020) Vol. 83, pp. 106944-106944
Open Access | Times Cited: 24
Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study
Marco Paolini, Y. Harrington, Federica Colombo, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 11, pp. 1070-1081
Open Access | Times Cited: 8
Nutritional therapy can reduce the burden of depression management in low income countries: A review
Moses B. Ekong, Clementina F. Iniodu
IBRO Neuroscience Reports (2021) Vol. 11, pp. 15-28
Open Access | Times Cited: 19
Structural covariance network of the hippocampus–amygdala complex in medication-naïve patients with first-episode major depressive disorder
Lianqing Zhang, Xinyue Hu, Yongbo Hu, et al.
Deleted Journal (2022) Vol. 2, Iss. 4, pp. 190-198
Open Access | Times Cited: 13
Structural and functional alterations of the hippocampal subfields in T2DM with mild cognitive impairment and insulin resistance: A prospective study
Chen Yang, Huiyan Zhang, Zihan Ma, et al.
Journal of Diabetes (2024) Vol. 16, Iss. 11
Open Access | Times Cited: 2
Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication or Cognitive-Behavior Therapy in Treatment-Naive Depression
Hua-Hsin Tai, Jungho Cha, Faezeh Vedaei, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16
Impaired hippocampal neurogenesis in vitro is modulated by dietary-related endogenous factors and associated with depression in a longitudinal ageing cohort study
Andrea Du Preez, Sophie Lefèvre‐Arbogast, Raúl González‐Domínguez, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 8, pp. 3425-3440
Open Access | Times Cited: 11
Right-side frontal-central cortical hyperactivation before the treatment predicts outcomes of antidepressant and electroconvulsive therapy responsivity in major depressive disorder
Hsin-Jung Tsai, Wei‐Cheng Yang, Shih‐Jen Tsai, et al.
Journal of Psychiatric Research (2023) Vol. 161, pp. 377-385
Closed Access | Times Cited: 6
Altered topology of individual brain structural covariance networks in major depressive disorder
Liangliang Ping, Shan Sun, Cong Zhou, et al.
Psychological Medicine (2023) Vol. 53, Iss. 14, pp. 6921-6932
Closed Access | Times Cited: 6
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study report
Jee Su Suh, Laura M. Fiori, Mohammad Ali, et al.
Psychoneuroendocrinology (2021) Vol. 132, pp. 105348-105348
Open Access | Times Cited: 15
Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?
Jennifer Severe, John F. Greden, Priyanka Reddy
FOCUS The Journal of Lifelong Learning in Psychiatry (2020) Vol. 18, Iss. 2, pp. 120-128
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top